FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

900000000000526001: REPLACED BY association reference set (foundation metadata concept)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT model component module (core metadata concept)

Descriptions:

Id Description Lang Type Status Case? Module
900000000001156010 REPLACED BY association reference set (foundation metadata concept) en Fully specified name Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)
900000000001157018 REPLACED BY association reference set en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)


13129 members. Search Members:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
REPLACED BY association reference set (foundation metadata concept) est un(e) (attribut) Historical association reference set (foundation metadata concept) true Inferred relationship Some

Members targetComponentId
Hydralazine hydrochloride 20mg injection powder vial (product) Hydralazine hydrochloride 20 mg powder for solution for injection vial
Hemangioma, no International Classification of Diseases for Oncology subtype (morphologic abnormality) Benign hemangioma
Acute non-A, non-B, non-C hepatitis (disorder) hépatite virale aiguë
Toxoplasma hepatitis Hepatitis caused by Toxoplasma gondii
Positron emission tomography myocardial rest imaging using rubidium 81 (procedure) Positron emission tomography myocardial rest imaging using rubidium-82 (procedure)
Positron emission tomography myocardial stress imaging using rubidium 81 (procedure) Positron emission tomography myocardial stress imaging using rubidium-82 (procedure)
Haemophilus influenzae immunization (procedure) vaccination contre l'Haemophilus influenzae de type B
Anti-D globulin needed (situation) Administration of human anti-D immunoglobulin needed (situation)
Human immunoglobulin g 10% injection solution vial (product) Product containing only human immunoglobulin G (medicinal product)
Human immunoglobulin g 16% injection solution vial (product) Product containing precisely human immunoglobulin G 160 milligram/1 milliliter conventional release solution for injection (clinical drug)
Human immunoglobulin g 10g powder for injection solution vial (product) Product containing only human immunoglobulin G (medicinal product)
Human immunoglobulin g 10g injection solution vial (product) Product containing only human immunoglobulin G (medicinal product)
Human immunoglobulin g 2.5g powder for injection solution vial (product) Product containing only human immunoglobulin G (medicinal product)
Human immunoglobulin g 20g injection solution vial (product) Product containing only human immunoglobulin G (medicinal product)
Human immunoglobulin g 5g powder for injection solution vial (product) Product containing only human immunoglobulin G (medicinal product)
immunoglobulines anti-D administrées Human anti-D immunoglobulin administered (situation)
immunoglobulines anti-D administrées Human anti-D immunoglobulin administered (situation)
Impotence (disorder) Erectile dysfunction
Psychogenic impotence Erectile dysfunction due to psychophysiologic disorder (disorder)
Inactive concept (inactive concept) Inactive value (foundation metadata concept)
Infection by site maladie infectieuse
Infection caused by Bicaulus (disorder) Infection by Varestrongylus
intervention axée sur une constatation clinique Procedure
Surgical procedure for clinical finding and/or disorder (procedure) Surgical procedure (procedure)
Therapeutic endoscopic procedure (procedure) intervention endoscopique
Additional preoperative procedure instituted by anesthetist (procedure) Preoperative procedure
intervention relative à une intervention Procedure
Abdominal packing procedures Insertion of pack into peritoneal cavity (procedure)
Postoperative procedures Postoperative procedure (procedure)
Preoperative procedures Preoperative procedure
Family Aceraceae poisoning Family Sapindaceae poisoning
Iritis with inflammatory bowel disease (disorder) Iritis co-occurrent with inflammatory bowel disease
kV kilovolt
leucémie mastocytaire classique Mast cell leukemia (clinical)
ligne de suture inflammée Suture line inflamed (finding)
lotrozole (product) Product containing letrozole (medicinal product)
Cutaneous T-cell lymphoma Cutaneous T-cell lymphoma
Diffuse large B-cell lymphoma - category (morphologic abnormality) Diffuse large B cell malignant lymphoma (morphologic abnormality)
Hodgkin lymphoma Hodgkin lymphoma
Nonallopathic lesion of rib cage Somatic dysfunction of thoracic region (finding)
mA mA - milliampere
mV millivolt (qualifier value)
Dupuytren contracture repaired by division of palmar aponeurosis (situation) Dupuytren contracture corrected by division of palmar aponeurosis
mammographie et biopsie Biopsy of breast using mammography guidance (procedure)
Damp environment Damp environment
Dirty environment Dirty environment (finding)
Secluded environment Secluded environment (finding)
Emotional environment Emotional environment finding (finding)
Alien environment Alien environment
Mother currently breast-feeding Mother currently breastfeeding
Product containing sodium diatrizoate (medicinal product) Product containing amidotrizoic acid (medicinal product)
Product containing only human insulin (medicinal product) Human insulin-containing product
Interferon alfa only product Interferon alfa-containing product
Product containing only mycophenolate mofetil (medicinal product) Product containing only mycophenolic acid (medicinal product)
Drugs used in metabolic disorders (product) Medicinal product categorised by therapeutic role
Drugs used in hyperuricemia (product) Medicinal product acting as uricosuric (product)
Methylprednisolone 1g powder and solvent for injection solution vial (product) Product containing precisely methylprednisolone (as methylprednisolone sodium succinate) 1 gram/1 vial powder for conventional release solution for injection (clinical drug)
Methylprednisolone 125mg powder and solvent for injection solution vial (product) Methylprednisolone (as methylprednisolone sodium succinate) 125 mg powder for solution for injection vial
Methylprednisolone 2g powder and solvent for injection solution vial (product) Product containing precisely methylprednisolone (as methylprednisolone sodium succinate) 2 gram/1 vial powder for conventional release solution for injection (clinical drug)
Methylprednisolone 40mg powder and solvent for injection solution vial (product) Methylprednisolone (as methylprednisolone sodium succinate) 40 mg powder for solution for injection vial
Methylprednisolone 500mg powder and solvent for injection solution vial (product) Methylprednisolone (as methylprednisolone sodium succinate) 500 mg powder for solution for injection vial
Metronidazole 5mg/mL infusion solution 100mL bag (product) Product containing precisely metronidazole 5 milligram/1 milliliter conventional release solution for injection (clinical drug)
n-1-Naphthyl sodium salt Herbicide
Pigmented nevus, no International Classification of Diseases for Oncology subtype (morphologic abnormality) Pigmented nevus
Nimodipine 200micrograms/mL infusion solution 50mL vial (product) Product containing precisely nimodipine 200 microgram/1 milliliter conventional release solution for injection (clinical drug)
nombre de lymphonœuds non régionaux atteints Number of lymph nodes containing metastatic neoplasm in excised specimen
note z Z-score calculation technique
Odontoma Benign odontoma
Oligodendroglioma, no ICD-O subtype Oligodendroglioma
Acute suppurative otitis media due to another disease otite moyenne aiguë suppurée
World Health Organization FRAX hip fracture probability assessment tool (assessment scale) FRAX (fracture risk assessment tool) hip fracture probability assessment tool
World Health Organization FRAX osteoporotic fracture probability assessment tool (assessment scale) FRAX (fracture risk assessment tool) osteoporotic fracture probability assessment tool
Product containing sodium oxybate (medicinal product) Product containing 4-hydroxybutyric acid (medicinal product)
p-Amino diphenylamine (substance) 4-aminobiphenyl (substance)
pM category finding (finding) American Joint Committee on Cancer pathological M category allowable value (qualifier value)
pM0 category (finding) American Joint Committee on Cancer cM0 (qualifier value)
pM0: No distant metastasis (breast) (finding) American Joint Committee on Cancer cM0 (qualifier value)
pM1 (IV): Distant metastasis (TNM category and FIGO stage) (fallopian tube) (finding) American Joint Committee on Cancer pM1 (qualifier value)
pM1 (IV): Distant metastasis (TNM category and FIGO stage) (ovary) (finding) American Joint Committee on Cancer pM1 (qualifier value)
pM1 (IVB): Distant metastasis (TNM category and FIGO stage) (corpus uteri) (finding) American Joint Committee on Cancer pM1 (qualifier value)
pM1 (IVB): Distant metastasis (TNM category and FIGO stage) (uterine cervix) (finding) American Joint Committee on Cancer pM1 (qualifier value)
pM1 (IVB): Distant metastasis (TNM category and FIGO stage) (vagina) (finding) American Joint Committee on Cancer pM1 (qualifier value)
pM1 (IVB): Distant metastasis (including pelvic lymph node metastasis) (TNM category and FIGO stage) (vulva) (finding) American Joint Committee on Cancer pM1 (qualifier value)
pM1 category (finding) American Joint Committee on Cancer pM1 (qualifier value)
pM1: Distant metastasis (breast) American Joint Committee on Cancer pM1 (qualifier value)
pM1: Distant metastasis, includes separate tumor nodule(s) in a different lobe (ipsilateral or contralateral) (lung) (finding) American Joint Committee on Cancer pM1 (qualifier value)
pM1a (III): Tumor extends to the lungs with or without genital tract involvement (TNM category and FIGO stage) (gestational trophoblast) (finding) American Joint Committee on Cancer pM1a (qualifier value)
pM1a category (finding) American Joint Committee on Cancer pM1a (qualifier value)
pM1a: Distant metastasis (esophagus) (finding) American Joint Committee on Cancer pM1a (qualifier value)
pM1a: Distant metastasis not applicable (midthoracic esophagus) (finding) American Joint Committee on Cancer pM1a (qualifier value)
pM1a: Distant metastasis to bone marrow (retinoblastoma) (finding) American Joint Committee on Cancer pM1a (qualifier value)
pM1a: Distant metastasis to lung (bone) (finding) American Joint Committee on Cancer pM1a (qualifier value)
pM1a: Distant metastasis to lung (primitive neuroectodermal tumor/Ewing's sarcoma) (finding) American Joint Committee on Cancer pM1a (qualifier value)
pM1a: Distant metastasis to non-regional lymph node(s) (prostate) (finding) American Joint Committee on Cancer pM1a (qualifier value)
pM1a: Metastasis in celiac lymph nodes (lower thoracic esophagus) (finding) American Joint Committee on Cancer pM1a (qualifier value)
pM1a: Metastasis in cervical nodes (upper thoracic esophagus) (finding) American Joint Committee on Cancer pM1a (qualifier value)
pM1a: Metastasis to skin, subcutaneous tissues, or distant lymph nodes (melanoma of the skin) (finding) American Joint Committee on Cancer pM1a (qualifier value)
pM1a: Non-regional nodal or pulmonary metastasis (testis) (finding) American Joint Committee on Cancer pM1a (qualifier value)
pM1b (IV): Distant metastasis other than lung (TNM category and FIGO stage) (gestational trophoblast) (finding) American Joint Committee on Cancer pM1b (qualifier value)
pM1b category (finding) American Joint Committee on Cancer pM1b (qualifier value)
pM1b: Distant metastasis (esophagus) (finding) American Joint Committee on Cancer pM1b (qualifier value)

Start Previous Page 125 of 132 Next End


Reference Sets

Canada French language reference set (foundation metadata concept)

Reference set descriptor

Back to Start